Cargando…

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China

Transcatheter repair of mitral regurgitation (MR) by edge‐to‐edge therapy has become increasingly accepted for patients with severe MR at high or prohibitive surgical risk in primary or degenerative mitral regurgitation (DMR). The technological approach has evolved from the initial transcatheter edg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xianbao, Pu, Zhaoxia, Lim, David Scott, Wang, Jian'an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546111/
https://www.ncbi.nlm.nih.gov/pubmed/33942968
http://dx.doi.org/10.1002/ccd.29687
_version_ 1784804969842475008
author Liu, Xianbao
Pu, Zhaoxia
Lim, David Scott
Wang, Jian'an
author_facet Liu, Xianbao
Pu, Zhaoxia
Lim, David Scott
Wang, Jian'an
author_sort Liu, Xianbao
collection PubMed
description Transcatheter repair of mitral regurgitation (MR) by edge‐to‐edge therapy has become increasingly accepted for patients with severe MR at high or prohibitive surgical risk in primary or degenerative mitral regurgitation (DMR). The technological approach has evolved from the initial transcatheter edge‐to‐edge device to improve on its acute reduction in MR and durability of results, particularly in complex primary pathology. In this study, we reported the first case of DragonFly™ Transcatheter Valve Repair device in a patient with severe DMR.
format Online
Article
Text
id pubmed-9546111
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95461112022-10-14 Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China Liu, Xianbao Pu, Zhaoxia Lim, David Scott Wang, Jian'an Catheter Cardiovasc Interv Valvular and Structural Heart Diseases Transcatheter repair of mitral regurgitation (MR) by edge‐to‐edge therapy has become increasingly accepted for patients with severe MR at high or prohibitive surgical risk in primary or degenerative mitral regurgitation (DMR). The technological approach has evolved from the initial transcatheter edge‐to‐edge device to improve on its acute reduction in MR and durability of results, particularly in complex primary pathology. In this study, we reported the first case of DragonFly™ Transcatheter Valve Repair device in a patient with severe DMR. John Wiley and Sons Inc. 2021-05-04 2022-02-01 /pmc/articles/PMC9546111/ /pubmed/33942968 http://dx.doi.org/10.1002/ccd.29687 Text en © 2021 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Valvular and Structural Heart Diseases
Liu, Xianbao
Pu, Zhaoxia
Lim, David Scott
Wang, Jian'an
Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title_full Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title_fullStr Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title_full_unstemmed Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title_short Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
title_sort transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel dragonfly™ transcatheter repair device—first in man implantation in china
topic Valvular and Structural Heart Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546111/
https://www.ncbi.nlm.nih.gov/pubmed/33942968
http://dx.doi.org/10.1002/ccd.29687
work_keys_str_mv AT liuxianbao transcathetermitralvalverepairinahighsurgicalriskpatientwithseveredegenerativemitralregurgitationusingthenoveldragonflytranscatheterrepairdevicefirstinmanimplantationinchina
AT puzhaoxia transcathetermitralvalverepairinahighsurgicalriskpatientwithseveredegenerativemitralregurgitationusingthenoveldragonflytranscatheterrepairdevicefirstinmanimplantationinchina
AT limdavidscott transcathetermitralvalverepairinahighsurgicalriskpatientwithseveredegenerativemitralregurgitationusingthenoveldragonflytranscatheterrepairdevicefirstinmanimplantationinchina
AT wangjianan transcathetermitralvalverepairinahighsurgicalriskpatientwithseveredegenerativemitralregurgitationusingthenoveldragonflytranscatheterrepairdevicefirstinmanimplantationinchina